表紙
市場調査レポート

心房細動:世界の治験レビュー

Atrial Fibrillation Global Clinical Trials Review, H2, 2013

発行 GlobalData 商品コード 230761
出版日 ページ情報 英文 191 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.12円で換算しております。
Back to Top
心房細動:世界の治験レビュー Atrial Fibrillation Global Clinical Trials Review, H2, 2013
出版日: 2013年12月30日 ページ情報: 英文 191 Pages
概要

当レポートでは、世界の心房細動治療薬の臨床試験について調査し、地域別の臨床市件数データ、試験段階、試験状況、採用テーマおよびスポンサー企業タイプ別の臨床試験データ、中断(一時中止、廃止、打ち切り)された試験のリストなどを提供しており、概略以下の構成でお届けします。

目次

  • イントロダクション
    • 心房細動
    • レポートガイダンス
  • 臨床試験:地域別
  • 臨床試験:国別
    • 臨床試験に寄与している上位5ヵ国 − アジア太平洋地域
    • 臨床試験に寄与している上位5ヵ国 − 欧州
    • 臨床試験に寄与している上位国 − 北米
    • 臨床試験に寄与している上位5ヵ国 − 中東およびアフリカ
    • 臨床試験に寄与している上位5ヵ国 − 中南米
  • 臨床試験 BRIC 諸国
  • 臨床試験 G7 諸国
  • 臨床試験 G7 諸国 , 治験ステータス別
  • 臨床試験 E7 諸国
  • 臨床試験 E7 諸国 , 治験ステータス別
  • 臨床試験:相別
    • 進行中の治験:相別
  • 臨床試験:治験ステータス別
  • 未完了の治験
  • 期間ごとの被験者数
  • 有力なスポンサー
    • 主な治験参加企業
  • 有望な治療薬比較
  • 臨床試験プロファイル
    • 臨床試験概要:上位企業
      • St. Jude Medical, Inc.
      • Sanofi
      • Medtronic, Inc.
      • AstraZeneca PLC
      • Boehringer Ingelheim GmbH
      • AtriCure, Inc.
      • Astellas Pharma Inc.
      • GlaxoSmithKline plc
      • Bristol-Myers Squibb Company
      • 第一三共
      • Biosense Webster EMEA
      • CardioFocus, Inc.
      • Merck & Co., Inc.
      • Bayer AG
      • Abbott Laboratories
      • Atritech, Inc.
      • Biotronik SE & Co. KG
      • Biosense Webster, Inc.
      • Boston Scientific Corporation
      • Pfizer Inc.
    • 臨床試験概要:トップレベルの大学 / 研究機関 / 病院
      • Deutsches Herzzentrum Munchen
      • Mayo Clinic
      • University of Pennsylvania
      • Emory University
      • Medtronic Bakken Research Center
      • University of Pittsburgh
      • The Cleveland Clinic
      • University Medical Center Groningen
      • Hospital Clinic de Barcelona
      • University of Calgary
      • Norwegian University of Science and Technology
      • Vanderbilt University
      • Rigshospitalet
      • Medical University of Vienna
      • Kuopio University Hospital
      • Creighton University
      • Montreal Heart Institute Research Centre
      • Eastbourne District General Hospital
      • Barts and The London NHS Trust
      • Brigham and Women's Hospital
  • 5件の主要臨床プロファイル

付録

図表一覧


このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC1911CTIDB

GlobalData's clinical trial report, "Atrial Fibrillation Global Clinical Trials Review, H2, 2013" provides data on the Atrial Fibrillation clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Atrial Fibrillation. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Atrial Fibrillation. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Atrial Fibrillation
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by BRIC Nations
  • Clinical Trials by G7 Nations
  • Clinical Trials in G7 Nations by Trial Status
  • Clinical Trials by E7 Nations
  • Clinical Trials in E7 Nations by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Unaccomplished Trials of Atrial Fibrillation
  • Subjects Recruited Over a Period of Time
  • Prominent Sponsors
    • Top Companies Participating in Atrial Fibrillation Therapeutics Clinical Trials
  • Prominent Drug Comparison
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • Medtronic, Inc.
      • Clinical Trial Overview of Medtronic, Inc.
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • C. H. Boehringer Sohn AG & Co. KG
      • Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG
      • Bayer AG
      • Clinical Trial Overview of Bayer AG
      • St. Jude Medical, Inc.
      • Clinical Trial Overview of St. Jude Medical, Inc.
      • Bristol-Myers Squibb Company
      • Clinical Trial Overview of Bristol-Myers Squibb Company
      • Cardiome Pharma Corp
      • Clinical Trial Overview of Cardiome Pharma Corp
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Daiichi Sankyo Company, Limited
      • Clinical Trial Overview of Daiichi Sankyo Company, Limited
    • Clinical Trial Overview of Top Institutes / Government
      • National Heart, Lung, and Blood Institute
      • Clinical Trial Overview of National Heart, Lung, and Blood Institute
      • Texas Cardiac Arrhythmia Research Foundation
      • Clinical Trial Overview of Texas Cardiac Arrhythmia Research Foundation
      • Meshalkin Research Institute of Pathology of Circulation
      • Clinical Trial Overview of Meshalkin Research Institute of Pathology of Circulation
      • Deutsches Herzzentrum Munchen
      • Clinical Trial Overview of Deutsches Herzzentrum Munchen
      • Mayo Clinic
      • Clinical Trial Overview of Mayo Clinic
      • Vanderbilt University
      • Clinical Trial Overview of Vanderbilt University
      • Medical University of Vienna
      • Clinical Trial Overview of Medical University of Vienna
      • University Medical Center Groningen
      • Clinical Trial Overview of University Medical Center Groningen
      • University of Pittsburgh
      • Clinical Trial Overview of University of Pittsburgh
      • Norwegian University of Science and Technology
      • Clinical Trial Overview of Norwegian University of Science and Technology
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Atrial Fibrillation Therapeutics Market, Global, Clinical Trials by Zone, 2013*
  • Atrial Fibrillation Therapeutics Market, Global, Clinical Trials by Top Countries, 2013*
  • Atrial Fibrillation Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013*
  • Atrial Fibrillation Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013*
  • Atrial Fibrillation Therapeutics Clinical Trials, Europe, Top Five Countries, 2013*
  • Atrial Fibrillation Therapeutics Clinical Trials, North America, Top Countries, 2013*
  • Atrial Fibrillation Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2013*
  • Atrial Fibrillation Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2013*
  • Atrial Fibrillation Therapeutics Clinical Trials, BRIC Countries, 2013*
  • Atrial Fibrillation Therapeutics Clinical Trials, G7 Countries, 2013*
  • Atrial Fibrillation Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013*
  • Atrial Fibrillation Therapeutics Clinical Trials, E7 Countries, 2013*
  • Atrial Fibrillation Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013*
  • Atrial Fibrillation Therapeutics Market, Global, Clinical Trials by Phase, 2013*
  • Atrial Fibrillation Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013*
  • Atrial Fibrillation Therapeutics Market, Global, Clinical Trials by Trial Status, 2013*
  • Atrial Fibrillation Therapeutics Market, Global, Suspended Clinical Trials, 2013*
  • Atrial Fibrillation Therapeutics Market, Global, Withdrawn Clinical Trials, 2013*
  • Atrial Fibrillation Therapeutics Market, Global, Terminated Clinical Trials, 2013*
  • Atrial Fibrillation Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012
  • Atrial Fibrillation Therapeutics Clinical Trials, Global, Key Sponsors, 2013*
  • Atrial Fibrillation Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013*
  • Atrial Fibrillation Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013*
  • Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2013*
  • Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Medtronic, Inc., 2013*
  • Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2013*
  • Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2013*
  • Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2013*
  • Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Jude Medical, Inc., 2013*
  • Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2013*
  • Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Cardiome Pharma Corp, 2013*
  • Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2013*
  • Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2013*
  • Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2013*
  • Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Texas Cardiac Arrhythmia Research Foundation, 2013*
  • Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Meshalkin Research Institute of Pathology of Circulation, 2013*
  • Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Deutsches Herzzentrum Munchen, 2013*
  • Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2013*
  • Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2013*
  • Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2013*
  • Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by University Medical Center Groningen, 2013*
  • Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2013*
  • Atrial Fibrillation Therapeutics Clinical Trials Market, Global, Clinical Trials by Norwegian University of Science and Technology, 2013*

List of Figures

  • Atrial Fibrillation Therapeutics Market, Global, Clinical Trials by Zone (%), 2013*
  • Atrial Fibrillation Therapeutics Market, Global, Clinical Trials by Top Countries, 2013*
  • Atrial Fibrillation Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013*
  • Atrial Fibrillation Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013*
  • Atrial Fibrillation Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013*
  • Atrial Fibrillation Therapeutics Clinical Trials, North America, Top Countries (%), 2013*
  • Atrial Fibrillation Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2013*
  • Atrial Fibrillation Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2013*
  • Atrial Fibrillation Therapeutics Clinical Trials, BRIC Countries (%), 2013*
  • Atrial Fibrillation Therapeutics Clinical Trials, G7 Countries (%), 2013*
  • Atrial Fibrillation Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013*
  • Atrial Fibrillation Therapeutics Clinical Trials, E7 Countries (%), 2013*
  • Atrial Fibrillation Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013*
  • Atrial Fibrillation Therapeutics Market, Global, Clinical Trials by Phase (%), 2013*
  • Atrial Fibrillation Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013*
  • Atrial Fibrillation Therapeutics Market, Global, Clinical Trials by Trial Status, 2013*
  • Atrial Fibrillation Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012
  • Atrial Fibrillation Therapeutics Clinical Trials, Global, Key Sponsors, 2013*
  • Atrial Fibrillation Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013*
  • Atrial Fibrillation Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013*
  • GlobalData Methodology
Back to Top